Radical prostatectomy versus external beam radiotherapy for localized prostate cancer: Comparison of treatment outcomes;Radikale Prostatektomie versus externe Strahlentherapie beim lokal begrenzten Prostatakarzinom: Vergleich der Behandlungsergebnisse

Strahlentherapie und Onkologie

Volumn 191, Issue 4, 2015, Pages 321-329

  Kim, Yeon Joo ^a   Cho, Kwan Ho ^a   Pyo, Hong Ryull ^b   Lee, Kang Hyun ^a   Moon, Sung Ho ^a   Kim, Tae Hyun ^a   Shin, Kyung Hwan ^a   Kim, Joo Young ^a   Kim, Young kyung ^a   Lee, Se Byeong ^a  

^a National Cancer Center   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Biochemical failure free survival; Disease specific survival; Prostate cancer; Prostatectomy; Radiotherapy

Indexed keywords

AGED; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; HUMAN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROCEDURES; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84933522126     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-014-0765-3     Document Type: Article

References (23)

1. Jung KW, Won YJ, Kong HJ (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1–14
2. Zeliadt SB, Ramsey SD, Penson DF et al (2006) Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer. Cancer 106:1865–1874
3. Jang TL, Bekelman JE, Liu Y et al (2010) Physician visits prior to treatment for clinically localized prostate cancer. Archives Intern Med 170:440–450
4. Lee DH, Jung HB, Chung MS (2013) The change of prostate cancer treatment in Korea: 5 year analysis of a single institution. Yonsei Med J 54:87–91
5. Kim YJ, Cho KH, Pyo HR et al (2013) A phase II study of hypofractionated proton therapy for prostate cancer. Acta oncologica (Stockholm, Sweden) 52:477–485
6. Stephenson AJ, Kattan MW, Eastham JA et al (2006) Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol 24:3973–3978
7. Roach M 3rd, Hanks G, Thames H Jr (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965–974
8. National Comprehensive Cancer Network guidelines (2013) http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf. Accessed 1 Aug 2013
9. D’amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969–974
10. Akakura K, Suzuki H, Ichikawa T (2006) A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Jpn J Clin Oncol 36:789–793
11. Kuban DA, Tucker SL, Dong L et al (2008) Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70:67–74
12. Kupelian PA (2002) Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy. J Clin Oncol 20:3376–3385
13. Arcangeli G, Strigari L, Arcangeli S et al (2009) Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 75:975–982
14. Zelefsky MJ, Eastham JA, Cronin AM et al (2010) Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol 28:1508–1513
15. Sooriakumaran P, Nyberg T, Akre O (2014) Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes. BMJ 348:g1502
16. Winkelmayer WC, Kurth T (2004) Propensity scores: help or hype? Nephrol Dial Transplant 19:1671–1673
17. Hoffman RM, Hunt WC, Gilliland FD et al (2003) Patient satisfaction with treatment decisions for clinically localized prostate carcinoma. Results from the Prostate Cancer Outcomes Study. Cancer 97:1653–1662
18. Fellin G, Rancati T, Fiorino C et al (2014) Long term rectal function after high-dose prostatecancer radiotherapy: results from a prospective cohort study. Radiother Oncol 110:272–277
19. Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124–1129
20. Guckenberger M, Ok S, Polat B et al (2010) Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 186:535–543
21. Ghadjar P, Gwerder N, Manser P et al (2010) High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer. Strahlenther Onkol 186:687–692
22. Razzaghdoust A, Mozdarani H, Mofid B (2014) Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I/II randomized placebo-controlled trial. Strahlenther Onkol 190:739–744
23. Bolla M, Van Poppel H, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 380:2018–2027